Today, 08:11 PM
Does PREP Act apply?
Neuralink is funded by 15 investors. Raison and Valor Equity Partners are the most recent investors. Neuralink has a post-money valuation in the range of $500M to $1B as of Jun 30, 2021, according to PrivCo.
In April 2017, Neuralink announced that it was aiming to make devices to treat serious brain diseases in the short-term, with the eventual goal of human enhancement, sometimes called transhumanism.
Neuralink tests their devices by surgically implanting them in the brains of live monkeys, pigs and other animals. Neuralink's methods have been criticized by groups such as PETA. From 2017 to 2020, Neuralink's experiments on monkeys were conducted in partnership with UC Davis. At the end of their partnership, UC Davis transferred seven monkeys to Neuralink. In 2022, the Physicians Committee for Responsible Medicine (PCRM) alleged that Neuralink and UC Davis had mistreated several monkeys, subjecting them to psychological distress, extreme suffering, and chronic infections due to surgeries. Experiments conducted by Neuralink and UC Davis have involved at least 23 monkeys, and the PCRM believes that 15 of those monkeys died or were euthanized as a result of the experiments. Furthermore, the PCRM alleged that UC Davis withheld photographic and video evidence of the mistreatment.
Connect With Us